Reproducible quantification of osteoclastic activity: Characterization of a biomimetic calcium phosphate assay

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 102, Issue 5, 2014, Pages 903-912

  Maria, Salwa M ^a,b   Prukner, Christiane ^c   Sheikh, Zeeshan ^a   Mueller, Frank ^c   Barralet, Jake E ^a   Komarova, Svetlana V ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

biomimetic substrate; hydroxyapatite; osteoclast; quantification; resorption

Indexed keywords

ANIMALS; ASSAYS; BIOMIMETICS; BODY FLUIDS; CELL CULTURE; DISEASES; HYDROXYAPATITE; SUBSTRATES;

ALENDRONATE; COATED SUBSTRATES; CULTURE PLATES; OSTEOCLAST; PHASE PURE HYDROXYAPATITES; QUANTIFICATION; RESORPTION; RHEUMATOID ARTHRITIS;

CALCIUM PHOSPHATE;

ALENDRONIC ACID; BIOMIMETIC MATERIAL; CALCITONIN; CALCIUM PHOSPHATE; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; BIOMIMETICS; CELL BEHAVIOR ASSAY; CELL SPECIFICITY; DISSOLUTION; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOLYSIS; ANIMAL; CELL LINE; CYTOLOGY; DRUG THERAPY; MATERIALS TESTING; METABOLISM;

ANIMALS; BIOMIMETIC MATERIALS; BONE RESORPTION; CALCIUM PHOSPHATES; CELL LINE; MATERIALS TESTING; MICE; OSTEOCLASTS;

EID: 84902466475     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.33071     Document Type: Article

References (40)

1. Hughes D, Dai A, Tiffee J, Li H, Mundy G, Boyce B,. Estrogen promotes apoptosis of murine osteoclasts mediated by TGFβ. Nat Med 1996; 2: 1132-1136.
2. Ritchlin C, Haas-Smith S, Li P, Hicks D, Schwarz E,. Mechanisms of TNFα- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003; 111: 821-831. (Pubitemid 37074957)
3. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ, Buckley CD,. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum. 2001; 44: 2633-2641. (Pubitemid 33049341)
4. Burman A, Haworth O, Hardie D, Amft E, Siewert C, Jackson D, Salmon M, Buckley C,. A chemokine dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005; 174: 1693-1700.
5. Page G, Lebecque S, Miossec P,. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: Correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002; 168: 5333-5341. (Pubitemid 34496002)
6. Bartold P, Cantley M, Haynes D,. Mechanisms and control of pathologic bone loss in periodontitis. Periodontol 2000; 53: 55-69.
7. Halvorson K, Sevcik M, Ghilardi J, Rosol T, Mantyh P,. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin J Pain 2006; 22: 587-600. (Pubitemid 44310159)
8. Jones S, Boyde A, Ali N,. The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts. Anat Embryol (Berl) 1984; 170: 247-256. (Pubitemid 15208293)
9. Kasten T, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko T, Settle S, Currie M, Nickols G,. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase (bone cell/nitric oxide/aminguanidine). Proc Natl Acad Sci U S A 1994; 91: 3569-3573. (Pubitemid 24139471)
10. Everts V, Korper W, Jansen D, Steinfort J, Lammerse I, Heera S, Docherty A, Beertsen W,. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 1999; 13: 1219-1230. (Pubitemid 29300367)
11. Boyde A, Jones S,. Pitfalls in pit measurement. Calcif Tissue Int 1991; 4: 5-70.
12. Ishizuka S, Kurihara N, Reddy S, Cornish J, Cundy T, Roodman G,. (23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease. Endocrinology 2005; 146: 2023-2030. (Pubitemid 40396913)
13. Hiruma Y, Kurihara N, Subler M, Zhou H, Boykin C, Zhang H, Ishizuka S, Dempster D, Roodman G, Windle J,. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment. Hum Mol Genet 2008; 17: 3708-3719.
14. Van'thof RJ, Ralston SH,. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 1997; 12: 1797-1804. (Pubitemid 27500191)
15. Schwartz Z, Lohmann C, Wieland M, Cochran D, Dean D, Textor M, Bonewald L, Boyan B,. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 2000; 71: 586-597. (Pubitemid 30602325)
16. 2+. Calcif Tissue Int 2003; 73: 265-273. (Pubitemid 37152888)
17. Ziyang Z, Egaña JT, Reckhenrich AK, Schenck TL, Lohmeyer JA, Schantz JT, Machens H-G, Schilling AF,. Cell-based resorption assays for bone graft substitutes. Acta Biomater 2012; 8: 13-19.
18. Miyazaki T, Miyauchi S, Anada T, Imaizumi H, Suzuki O,. Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion. Anal Biochem 2011; 410: 7-12.
19. Winkler T, Hoenig E, Gildenhaar R, Berger G, Fritsch D, Janssen R, Morlock M, Schilling A,. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities. Acta Biomater 2010; 6: 4127-4135.
20. Doi Y, Iwanaga H, Shibutani T, Moriwaki Y, Iwayama Y,. Osteoclastic responses to various calcium phosphates in cell cultures. J Biomed Mater Res 1999; 47: 424-433.
21. Oh S-A, Lee G-S, Park J-H, Kim H-W,. Osteoclastic cell behaviors affected by the alpha-tricalcium phosphate based bone cements. J Mater Sci: Mater Med 2010; 21 (11): 3019-3027.
22. Rochet N, Balaguer T, Boukhechba F, Laugier J, Quincey D,. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement. Biomaterials 2009; 30: 4260-4267.
23. Siebers M, Matsuzaka K, Walboomers X, Leeuwenburgh S, Wolke J, Jansen J,. Osteoclastic resorption of calcium phosphate coatings applied with electrostatic spray deposition (ESD), in vitro. J Biomed Mater Res A 2005; 74A: 570-580. (Pubitemid 41216259)
24. Long T, Hong F, Shen S, Wang L, Wang Y, Wang J,. In vitro degradation of electrodeposited calcium phosphate coatings by osteoclast-like cells. Biomed Mater 2012; 7: 045012.
25. Patntirapong S, Habibovic P, Hauschka P,. Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials 2009; 30: 548-555.
26. Akchurin T, Aissiou T, Kemeny N, Prosk E, Nigam N, Komarova SV,. Complex dynamics of osteoclast formation and death in long-term cultures. PLoS One 2008; 3: 2104.
27. Le Nihouannen DL, Hacking S, Gbureck U, Komarova S, Barralet J,. The use of RANKL-coated brushite cement to stimulate bone remodelling. Biomaterials 2008; 29: 3253-3259.
28. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL,. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999; 145: 527-538. (Pubitemid 29215717)
29. Hodge JM, Collier FM, Pavlos NJ, Kirkland MA, Nicholson GC,. M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts. PLoS One 2011; 6: e21462.
30. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ,. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 2000; 97: 1566-1571. (Pubitemid 30118482)
31. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K,. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998; 253: 395-400. (Pubitemid 29026714)
32. Carano A, Teitelbaum S, Konsek J, Schlesinger P, Blair H,. Bisphosphonates directly inhibit the bone resorption. activity of isolated avian osteoclasts in vitro. J Clin Invest 1990; 85: 456-461. (Pubitemid 20070052)
33. Williams C, Meachim G, Taylor W,. Effect of calcitonin treatment on osteoclast counts in Paget's disease of bone. J Clin Pathol 1978; 31: 1212-1217. (Pubitemid 9101536)
34. Samura A, Wada S, Suda S, Iitaka M, Katayama S,. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-κB ligand and macrophage colony-stimulating factor. Endocrinology 2000; 141 (10): 3774-3782.
35. Xia Z, Grover L, Huang Y, Adamopoulos I, Gbureck U, Triffitt J, Shelton R, Barralet J,. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials 2006; 27: 4557-4565. (Pubitemid 43783221)
36. Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ,. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001; 296: 235-242. (Pubitemid 32112446)
37. Virtanen SS, Väänänen HK, Härkönen PL, Lakkakorpi PT,. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002; 62: 2708-2714. (Pubitemid 34462756)
38. Green JR,. Bisphosphonates: preclinical review. Oncologist 2004; 9 (4): 3-13. (Pubitemid 39363164)
39. Warshafsky B, Aubin JE, Heersche JNM,. Cytoskeleton rearrangements during calcitonin-induced changes in osteoclast motility in vitro. Bone 1985; 6: 179-185. (Pubitemid 15021920)
40. Baron R, Neff L, Brown W, Louvard D, Courtoy PJ,. Selective internalization of the apical plasma membrane and rapid redistribution of lysosomal enzymes and mannose 6 phosphate receptors during osteoclast inactivation by calcitonin. J Cell Sci 1990; 97: 439-447. (Pubitemid 20374485)